You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent/ Refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Tumors Trial in Zhengzhou (First dose, Second dose, The third dose)

Recruiting
  • Gastrointestinal Tumors
  • First dose
  • +3 more
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Nov 22, 2023

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Recurrent/Refractory Classical Hodgkin's Lymphoma Trial in Tianjin (AK105,Anrotinib HCl)

Enrolling by invitation
  • Recurrent/Refractory Classical Hodgkin's Lymphoma
  • AK105，Anrotinib hydrochloride
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 12, 2023

Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
  • (no location specified)
Sep 5, 2023

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

Recurrent Refractory Mantle Cell Lymphoma

Recruiting
  • Mantle Cell Lymphoma
    • Beijing, Beijing, China
      Peking University Third Hospital
    Aug 1, 2022

    Recurrent/Refractory Malignant Lymphoma Trial in Beijing (JS004 , Recombinant humanized IgG4k mAb specific to BTLA for injection

    Recruiting
    • Recurrent/Refractory Malignant Lymphoma
    • JS004 , Recombinant humanized IgG4k monoclonal antibody specific to BTLA for injection Intravenous infusion
    • Drug：JS001, Intravenous infusion
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 13, 2022

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

    Recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • HER2-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Recurrent/Refractory Lymphoma Trial in Guiyang (Mitoxantrone Hydrochloride Liposome Injection)

    Completed
    • Recurrent/Refractory Lymphoma
    • Mitoxantrone Hydrochloride Liposome Injection
    • Guiyang, Guizhou, China
      Guizhou Cancer Hospita
    Dec 12, 2021

    Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

    Recruiting
    • Peripheral Nerve Sheath Tumor
    • Gainesville, Florida
      University of Florida
    Jan 4, 2023

    Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

    Not yet recruiting
    • Refractory
    • +2 more
    • GTP regimen
    • (no location specified)
    Sep 8, 2023

    Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

    Recruiting
    • Extensive-stage Small Cell Lung Cancer
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 27, 2023

    Colorectal Tumors Trial in Shanghai (TEC)

    Recruiting
    • Colorectal Neoplasms
    • Shanghai, Shanghai, China
      Tianshu Liu
    Apr 11, 2022

    Refractory/Recurrent Primary CNS Lymphoma (PCNSL) Trial in United States (Ibrutinib, Copanlisib)

    Recruiting
    • Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)
    • Basking Ridge, New Jersey
    • +6 more
    Jul 27, 2022

    Neuromyelitis Optica Trial in Hangzhou (CD19 CAR-T cells injection)

    Recruiting
    • Neuromyelitis Optica
    • CD19 CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 12, 2023

    Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

    Recruiting
    • Recurrent Childhood Acute Myeloid Leukemia
    • +17 more
      • Miami, Florida
        Nicklaus Children's Hospital
      May 13, 2023

      Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

      Not yet recruiting
      • Diffuse Intrinsic Pontine Glioma
      • +4 more
      • SC-CAR4BRAIN
      • Seattle, Washington
        Seattle Children's Hospital
      Mar 3, 2023

      Langerhans Cell Histiocytosis, LCH Trial (FCN-159)

      Not yet recruiting
      • Langerhans Cell Histiocytosis
      • LCH
      • (no location specified)
      Aug 15, 2023

      Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

      Active, not recruiting
      • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
      • Los Angeles, California
      • +20 more
      Jan 4, 2023

      Cancer Trial in Beijing (LVGN7409)

      Recruiting
      • Cancer
      • LVGN7409
      • Beijing, Beijing, China
        Center Hospital Chinese Academy of Medical Sciences
      Dec 7, 2021

      Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

      Recruiting
      • Malignant Abdominal Neoplasm
      • +26 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 5, 2023

      Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

      Recruiting
      • Colon Cancer
      • Chimeric antigen receptor T cell preparation targeting GCC
      • Qingdao, Shandong, China
        The Affiliated Hospital of Qingdao University
      May 16, 2023

      Osteosarcoma Trial (Vactosertib)

      Not yet recruiting
      • Osteosarcoma
      • (no location specified)
      Oct 18, 2022

      Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

      Recruiting
      • Colorectal Carcinoma
      • +21 more
      • Dual X-ray Absorptiometry
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jan 30, 2023

      Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the

      Completed
      Has Results
      • Triple Negative Breast Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 17, 2021